Per­cep­tive's $310M US/Chi­na play woos new CEO from Eli Lil­ly's top-speed bam­lanivimab team

For any fledg­ling biotech, re­cruit­ing the right CEO is cru­cial. But it’s an es­pe­cial­ly tough find for the new gen­er­a­tion of cross-bor­der star­tups with glob­al am­bi­tions.

Ide­al­ly, you want some­one who is ready to blaze a speedy path from clin­i­cal de­vel­op­ment to launch and be well-equipped to man­age the prod­uct life cy­cle — which re­quires a lev­el of in­sid­er knowl­edge about how US and Eu­ro­pean com­pa­nies op­er­ate and how to nav­i­gate reg­u­la­to­ry and com­mer­cial­iza­tion land­scapes in Chi­na.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER